# About Prescribed BPC-157: An Editorial Reading Room on the Record

> Prescribed BPC-157 is an independent editorial project that publishes summaries of the peer-reviewed BPC-157 literature. Not a clinic, not a vendor, not a prescriber.

An independent editorial reading room on the published BPC-157 literature — what it is, and what it is not.

## What this site is

Prescribed BPC-157 is an independent editorial project that publishes summaries of the peer-reviewed research literature on BPC-157. We read the published record — the primary studies, the reviews, the pharmacokinetic data, and the FDA regulatory documents — and set it out as a curated register of record: each finding attributed, each figure cited. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The black-tie reading-room treatment is deliberate. BPC-157's literature is a thirty-year lineage — the 1993 hepatoprotection paper, the 2003 transected-Achilles result, the 2004 gastric-ulcer cytoprotection figures, the 2017 VEGFR2 angiogenesis mechanism, the 2022 pharmacokinetic characterization, and the first small human pilots of 2024 and 2025 — and we render that pedigree as an engraved register rather than a supplement landing page.

## What the name means

The word "prescribed" in the domain is editorial framing, not a claim about services. It marks the position this publisher takes relative to the literature — the formal, medicinal-access register where questions of FDA status, the 503A bulk-substance category, and how compounded access works in general are read carefully and cited to the FDA. It does not mean the site prescribes anything, employs prescribers, or offers consultation, treatment, or prescription services. There are no doctors here, no pharmacists, no clinical team — only an editorial one, summarizing a body of research.

## How we handle the evidence

We lead with what was measured and attribute after. Every quantitative claim — a dose, a half-life, a percentage, a study population — maps to a numbered citation on the [BPC-157 references and citations](/references) page. We distinguish carefully between what the animal record establishes and what the human record does, because for BPC-157 that gap is the whole story: a broad preclinical literature and only three small human pilot studies [8][9][13]. Where the evidence is thin, we say so plainly, and we keep the honest caveats — non-regulated availability, single-group replication questions, unapproved status — in plain view rather than buried.

---

An engraved register of the BPC-157 literature, read in gold on black — not a clinic, not a pharmacy, not a prescription, and nothing here is for sale.